Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0092 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0051 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 |
filingDate |
2005-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2007-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e7989ce61a8d89a21f6373e2a87115f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af73091e27d7e246b0448983c85b26ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_670e1502349b4a1d04ce521e1e28eb23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4e171b9fedb82c455617ba3595fca12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1baa0fc13d8d2d4b7b8d158e2383c162 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_732c8ad74f514230a0d16b253a555ffc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ade70392cb1df1b50582a9361ef0c842 |
publicationDate |
2007-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1750688-B1 |
titleOfInvention |
Steroid intraocular implants having an extended sustained release for a period of greater than 2 months |
abstract |
Biocompatible intraocular implants include a steroid and a polymer associated with each other to facilitate release of the steroid into an eye for a period of time greater than about two months. The steroid may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. Or, the steroid may be associated with a polymeric coating having one or more openings effective to permit the steroid to be released into an external environment. The implants may be placed in an eye to treat one or more ocular conditions. The steroid is released from the implant for more than about two months, and may be release for more than several years. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014341966-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11185441-B2 |
priorityDate |
2004-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |